Tracheostomy Weaning Protocol for Intensive Care Patients
(DECAP-ICU Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to help patients in intensive care units remove tracheostomies, which are breathing tubes in the throat. Researchers compare a method based on how often patients need suctioning (removing mucus) with the usual method that assesses how long they can tolerate capping (closing off the tube). The trial aims to determine if the suctioning-based method leads to better outcomes. It targets individuals who have been off a ventilator for at least 24 hours and are in the process of removing the tracheostomy. As an unphased trial, this study offers patients the chance to contribute to innovative research that could enhance recovery processes in intensive care.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this weaning tracheostomy technique is safe for intensive care patients?
Research shows that a tracheostomy can increase patient comfort and simplify procedures like tube changes and suctioning compared to a breathing tube through the mouth or nose. Studies on the frequency of suctioning to determine when to remove the tracheostomy have shown positive results. This approach might reduce the time patients need the tracheostomy, indicating improved safety.
No reports have linked serious side effects directly to this suctioning-based method. Although researchers are still studying this treatment, the absence of major negative outcomes so far suggests it is well-tolerated. It is important to remember that this method remains under investigation, and further information will help confirm its safety.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores a new approach to weaning patients off tracheostomy in intensive care. The suction-based protocol being tested differs from the usual care by focusing on the frequency of suctioning as a key indicator for readiness to remove the tracheostomy tube. This method aims to streamline the weaning process by using a high-flow nasal cannula and setting clear criteria for decannulation, potentially leading to faster recovery and shorter ICU stays compared to traditional capping trials.
What evidence suggests that this weaning protocol is effective for intensive care patients?
Research has shown that a suctioning method can shorten the time needed to remove a tracheostomy tube. In this trial, participants will follow either a suction-based protocol or usual care, which involves high-flow oxygen therapy with capping. The suctioning approach proved effective in successfully removing the breathing tube. Patients using this method experienced better outcomes, including less time on a ventilator. Additionally, many did not require reinsertion of the tube. These findings suggest that the suctioning method could lead to quicker recovery and shorter hospital stays for patients with tracheostomies in intensive care.13567
Are You a Good Fit for This Trial?
This trial is for patients in the ICU who have been weaned off mechanical ventilation for at least a day and are ready within 24 hours to try decannulation. It's not suitable for those with severe conditions like a high Sabadell score, low Glasgow Coma Scale, blocked airways, long-term tracheostomy needs, serious swallowing issues, or certain neuromuscular diseases.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a weaning tracheostomy technique based on suctioning frequency compared to standard capping tolerance
Follow-up
Participants are monitored for safety and effectiveness after decannulation
What Are the Treatments Tested in This Trial?
Interventions
- Suctioning based protocol
- Usual Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Université de Sherbrooke
Lead Sponsor